For in-vitro research only · Not for human use · 18+

New prices. Permanently 30% lower.Already marked down from original prices · No code needed
Back to catalogue
Retatrutide 10mg research peptide vial — Aussie Peptides
Incretin-receptor agonists

Product illustration — not a lot photograph or test evidence.

Retatrutide 10 mgResearch peptide

$94.50

per vial

$135.00

In stock

Price is per single vial.

1

Batch documents: Not published online

Laboratory research listing — not offered for human or veterinary use. 18+. Full notice

Details

Research overview

Retatrutide (also catalogued as LY3437943) is classified as: triple GIP / GLP-1 / glucagon receptor agonist peptide. Aussie Peptides lists it as a research reference material in a 10mg presentation. The identifiers below are drawn from public chemical references; batch-specific results are available only where a report for that lot has been published.

Reference data

Retatrutide molecular information

Also known as
LY3437943
Classification
Triple GIP / GLP-1 / glucagon receptor agonist peptide
Look up Retatrutide on PubChem

Batch documentation for Retatrutide 10mg

No batch report is published online for this product yet. When one is, it will be matched to its lot number on the verify page. Check a lot number · How to read a batch report

Aussie Peptides brand mark

Aussie Peptides · specification

Retatrutide 10 mg

Labelled amount
10mg
SKU
RETATRUTIDE-10MG
Batch report
Not published online
Handling data
Supplier SDS and your institutional SOP
Category
Incretin-receptor agonists

Batch results apply only to the lot they were measured on. Where a report has been published for your lot, it can be looked up on the verify page.

Check a lot →Reading a batch report →

Batch documentation

Not published online for this product yet.

Look up a lot number · About batch reports

Laboratory handling

Handling & documentation

Aussie Peptides does not publish product- or lot-specific stability, storage-duration or preparation data for Retatrutide 10 mg. Base storage, reconstitution and disposal on the supplier safety data sheet (SDS) and your institution's standard operating procedures.

  • Record the lot number and expiry printed on the label when the item is received.
  • Check the verify page for a published batch report matching that lot.
  • Wear appropriate PPE and dispose of vials, sharps and unused material under your institution's waste procedures.

Ask by email if you need the supplier SDS for this item. Contact

No dosage advice

Aussie Peptides does not publish, supply or advise on human or veterinary dosing, administration or therapeutic use of any product, and nothing on this page should be read as such or as medical advice.

Products are listed for laboratory research and are not offered for human or animal consumption. A “research use only” label does not by itself determine regulatory status.

Research-use notice
Shipping

Shipping within Australia. Rates are set out in the shipping policy and match checkout; courier delivery times are estimates, not guarantees.

Questions

Retatrutide 10 mg — frequently asked

What is Retatrutide?+

Retatrutide (also catalogued as LY3437943) is classified as: triple GIP / GLP-1 / glucagon receptor agonist peptide. Aussie Peptides lists it as a research reference material in a 10mg presentation. The identifiers below are drawn from public chemical references; batch-specific results are available only where a report for that lot has been published.

Is a batch report published for Retatrutide 10mg?+

Not at the moment. No batch report is published online for this product. Results belong to a specific lot; if a report is published later it will be matched to its lot number on the verify page, and you can ask by email whether one is available.

Check a lot numberHow to read a batch report

Where do I find storage and handling information for Retatrutide?+

Aussie Peptides does not publish product- or lot-specific stability, storage-duration or preparation data for this item. Use the supplier safety data sheet (SDS) and your institution's standard operating procedures, and record the lot number printed on the vial.

What is the intended use of Retatrutide?+

It is listed for laboratory research and is not offered for human or veterinary use. A “research use only” label does not by itself determine a product's regulatory status in Australia; the TGA explains how it regulates peptide products. Purchasers remain responsible for their own legal and institutional obligations.

Intended use and complianceTGA guidance on peptide products

How much is Retatrutide 10mg and how is it shipped?+

The listed price is $94.50. The catalogue currently lists it as in stock. Current shipping rates and delivery estimates are set out in the shipping policy. Delivery times are courier estimates, not guarantees.

Shipping policy

Keep exploring

More from Incretin-receptor agonists